Rather than depending on diffusion, this nanoparticle targeted epithelial cell adhesion molecule (EpCAM) receptors overexpressed in RB cells by attaching EpCAM to the surface of the MSNPs loaded with carboplatin (CRB). This evidence concerns the gene EPCAM and retinoblastoma.